NCT04738643Completed
Improving Tobacco Treatment Rates for Cancer Patients Who Smoke
Source: ClinicalTrials.gov · Last updated 8 May 2025
Brief summary (registry, in English)
The research objective is to identify a simple, pragmatic, innovative way of enhancing Tobacco Use Treatment (TUT) rates within oncology. To investigate this possibility, the investigators propose methods that will allow them to: 1) evaluate the impact of standing orders to initiate a varenicline management protocol within outpatient cancer treatment workflow, 2) assess the potential for an EHR-based intervention to affect patient TUT behaviors, and 3) identify important facilitators and barriers that impact effectiveness of the intervention. The investigators will assess whether including a standing order for prescription and management of varenicline (TUT Service+VM) within the workflow for cancer patients identified as current smokers will significantly increase TUT engagement rates compared to current standard of care (TUT Service alone). The investigators hypothesize that observed treatment engagement rates will be higher among clinicians exposed to TUT Service+VM than observed in clinicians exposed to TUT Service alone.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 685 (actual)
- First submitted
- 28 Jan 2021
- Start date
- 28 Jun 2022
- Primary completion date
- 31 Dec 2023
- Lead sponsor
- Abramson Cancer Center at Penn Medicine
- Diseases
- Childhood cancers
- NCT number
- NCT04738643
What you commit to
- Study type: Interventional
- Participants enrolled: 685
- From 28 Jun 2022 to the primary completion date, 31 Dec 2023
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Unwillingness to prescribe varenicline, or
- Unwillingness to assign varenicline management to TUT Service providers.
Who the study is looking for
- Currently in active practice within Medical and Radiation Oncology divisions of ACC,
- Prescribing authority in Pennsylvania (i.e. physician, nurse practitioner, physician assistant),
- Nonsmoker,
- Has cared for at least one patient with tobacco use disorder in the 30 days prior to recruitment,
- English speaking, and
- Willing to provide informed consent to participate.
Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Penn Presbyterian Medical Center Coordinator of this site? Confirm its status | Philadelphia | United States | Unknown status |
| University of Pennsylvania Coordinator of this site? Confirm its status | Philadelphia | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.